Control Bionics (ASX:CBL) General and Admin. Expense: A$6.57 Mil (TTM As of Dec. 2025)


What is Control Bionics General and Admin. Expense?

Control Bionics ASX:CBL -3.53% General and Admin. Expense is A$6.57 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Control Bionics's General and Admin. Expense for the six months ended in Dec. 2025 was A$3.09 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 was A$6.57 Mil.

Control Bionics General and Admin. Expense Related Terms

Control Bionics General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Control Bionics's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Control Bionics General and Admin. Expense Chart

Control Bionics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
General and Admin. Expense
Get a 7-Day Free Trial 4.27 4.91 5.29 5.67 6.90

Control Bionics Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.28 2.39 3.42 3.48 3.09

Control Bionics General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$6.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of A$6.57 Mil mean?
Control Bionics (ASX:CBL) has a General and Admin. Expense of A$6.57 Mil as of Dec. 2025. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Control Bionics and its competitors.
Is Control Bionics' General and Admin. Expense too high?
Control Bionics' current General and Admin. Expense is A$6.57 Mil.
How does Control Bionics' General and Admin. Expense compare to ABT and SYK?
Control Bionics' General and Admin. Expense of A$6.57 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Medical Devices & Instruments company?
A good General and Admin. Expense depends on the Medical Devices & Instruments industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Control Bionics and its competitors. Control Bionics's current General and Admin. Expense is A$6.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Control Bionics stock overvalued right now?
Based on GuruFocus' analysis, Control Bionics (ASX:CBL) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.08 — trading 173.3% above its estimated fair value. The current General and Admin. Expense is A$6.57 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Control Bionics (ASX:CBL), the current General and Admin. Expense is A$6.57 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Control Bionics Business Description

Address 11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically, it derives a majority of revenue from North America and has its presence in Australia as well.